tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0MH6 Stock Latest News

Ipsen Advances Phase III Aesthetics Bet With New IPN10200 Frown-Line Study
Company AnnouncementsIpsen Advances Phase III Aesthetics Bet With New IPN10200 Frown-Line Study
3d ago
0MH6
Ipsen’s Tazemetostat Trial in Tough Lymphoma Group Withdrawn: What Investors Should Know
PremiumCompany Announcements
Ipsen’s Tazemetostat Trial in Tough Lymphoma Group Withdrawn: What Investors Should Know
1M ago
0MH6
Ipsen’s CaboLife Study: Real-World Cancer Data That Could Shape Cabozantinib’s Market Future
PremiumCompany Announcements
Ipsen’s CaboLife Study: Real-World Cancer Data That Could Shape Cabozantinib’s Market Future
2M ago
0MH6
Ipsen’s New Study on Tazemetostat: A Potential Game-Changer for Follicular Lymphoma
PremiumCompany Announcements
Ipsen’s New Study on Tazemetostat: A Potential Game-Changer for Follicular Lymphoma
3M ago
0MH6
Ipsen’s Dysport® vs. Botox®: A Completed Study on Upper Limb Spasticity
PremiumCompany Announcements
Ipsen’s Dysport® vs. Botox®: A Completed Study on Upper Limb Spasticity
3M ago
0MH6
Ipsen’s Genetic Study on PFIC: A Potential Game-Changer for Liver Disorder Diagnosis
PremiumCompany AnnouncementsIpsen’s Genetic Study on PFIC: A Potential Game-Changer for Liver Disorder Diagnosis
4M ago
0MH6
Ipsen’s New Study on IPN60300: A Potential Game-Changer for Advanced Tumours
Premium
Company Announcements
Ipsen’s New Study on IPN60300: A Potential Game-Changer for Advanced Tumours
5M ago
0MH6
Ipsen’s New Study on IPN01203: A Potential Game-Changer for Advanced Tumour Treatment
Premium
Company Announcements
Ipsen’s New Study on IPN01203: A Potential Game-Changer for Advanced Tumour Treatment
5M ago
0MH6
Ipsen’s New Study on Odevixibat: Long-term Insights for PFIC Treatment
PremiumCompany Announcements
Ipsen’s New Study on Odevixibat: Long-term Insights for PFIC Treatment
5M ago
0MH6
Ipsen’s Odevixibat Study: A Potential Game-Changer for Alagille Syndrome
PremiumCompany Announcements
Ipsen’s Odevixibat Study: A Potential Game-Changer for Alagille Syndrome
6M ago
0MH6
Ipsen’s Real-World Study on Cabozantinib and Nivolumab: A Potential Game-Changer for RCC Treatment
PremiumCompany Announcements
Ipsen’s Real-World Study on Cabozantinib and Nivolumab: A Potential Game-Changer for RCC Treatment
6M ago
0MH6
Ipsen’s Innovative Approach to PBC: A Study on Itch and Sleep Patterns
PremiumCompany Announcements
Ipsen’s Innovative Approach to PBC: A Study on Itch and Sleep Patterns
6M ago
0MH6
Ipsen’s New Study on Palovarotene: Implications for Liver-Impaired Patients
PremiumCompany AnnouncementsIpsen’s New Study on Palovarotene: Implications for Liver-Impaired Patients
6M ago
0MH6
Ipsen’s Odevixibat Study: A Closer Look at Pregnancy and Lactation Safety
Premium
Company Announcements
Ipsen’s Odevixibat Study: A Closer Look at Pregnancy and Lactation Safety
6M ago
0MH6
Ipsen’s Latest Clinical Study on IPN01194: A Potential Game-Changer in Oncology
Premium
Company Announcements
Ipsen’s Latest Clinical Study on IPN01194: A Potential Game-Changer in Oncology
6M ago
0MH6
Ipsen’s Phase II Osteosarcoma Study: A Potential Game Changer?
PremiumCompany Announcements
Ipsen’s Phase II Osteosarcoma Study: A Potential Game Changer?
6M ago
0MH6
Ipsen’s Real-World Study on Elafibranor for PBC: A Potential Game-Changer?
PremiumCompany Announcements
Ipsen’s Real-World Study on Elafibranor for PBC: A Potential Game-Changer?
6M ago
0MH6
Ipsen’s Elafibranor Study: A Potential Breakthrough for PBC Treatment
PremiumCompany Announcements
Ipsen’s Elafibranor Study: A Potential Breakthrough for PBC Treatment
6M ago
0MH6
Ipsen’s Promising Phase II Migraine Study: A Potential Game Changer
PremiumCompany Announcements
Ipsen’s Promising Phase II Migraine Study: A Potential Game Changer
6M ago
0MH6
Ipsen’s Latest Study on Abobotulinumtoxin A: Implications for Investors
PremiumCompany AnnouncementsIpsen’s Latest Study on Abobotulinumtoxin A: Implications for Investors
6M ago
0MH6
Ipsen’s Promising Study on IPN10200 for Cervical Dystonia: A Potential Game-Changer?
Premium
Company Announcements
Ipsen’s Promising Study on IPN10200 for Cervical Dystonia: A Potential Game-Changer?
6M ago
0MH6
Ipsen’s New Drug Study: A Potential Game-Changer for Advanced Solid Tumors
Premium
Company Announcements
Ipsen’s New Drug Study: A Potential Game-Changer for Advanced Solid Tumors
6M ago
0MH6

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >